Small Molecules

Meet CPI: the UK not-for-profit dedicated to de-risking innovation.

Will the antibiotic apocalypse kill us all?

Do you want to share the story behind your technology in a future issue of The Medicine Maker?

Sitting Down With… Brian Henry, Vice President of Drug Product Design, Pharmaceutical Sciences department at Pfizer.

Continuous wet granulation will be the star of a new UK facility, which stems from a collaboration between CPI, GSK and AstraZeneca.

A number of aspects must be considered to design a tablet that is well suited for commercial manufacture.

The tablet press is a pharma manufacturing facility staple, but today’s systems need to be faster, more reliable and more flexible than ever before.

By simulating processes in a digital twin of a facility, changes can be safely tested before application in the real world.

Dry granulation offers several advantages to manufacturers and it’s now attracting more attention with the push towards continuous manufacturing.

Will 3D inkjet printing enable the manufacture of personalized tablets?